Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
239.8 BRL | +0.57% |
|
-4.19% | +22.63% |
06-14 | UBS Trims Price Target on Altria to $36 From $36.50, Maintains Sell Rating | MT |
06-06 | US FDA rescinds market denial order for Juul products | RE |
Evolution of the average Target Price on Altria Group, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Altria Group, Inc.
UBS | |
Jefferies & Co. | |
Goldman Sachs | |
Morgan Stanley | |
Citigroup | |
Stifel Nicolaus | |
RBC Capital Markets | |
BofA Securities | |
Deutsche Bank Securities | |
Barclays | |
Cowen | |
Bernstein | |
Redburn | |
Argus | |
JEFFERIES | Owen Bennett |
EPS Revisions
- Stock Market
- Equities
- MO Stock
- MOOO34 Stock
- Consensus Altria Group, Inc.